Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Dr. James A. HelliwellCEO & Director | 150,00k | 83,43k | Derivative Exercise and Retained Stock | 0,56 | 1,06M | 16,57% |
| 2026-03-09 | Dr. Richard M. GlickmanIndependent Director | -3,13k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-27 | Dr. Simon N. PimstoneIndependent Chairman | 12,00k | 81,82k | Achat | 6,77 - 6,88 | 48,68k | 32,72% |
| 2026-03-27 | Dr. James A. HelliwellCEO & Director | 30,00k | 64,88k | Derivative Exercise and Retained Stock | 2,16 | 905,01k | 3,43% |
| 2026-03-18 | Mr. Joseph S. FreedmanIndependent Director | 18,70k | 145,85k | Achat | 7,42 - 7,97 | 2,54M | 0,74% |
| 2026-03-18 | PNG Enterprise FoundationSociété | -15,00k | 85,45k | Derivative Exercise and Sale | 2,19 - 7,89 | 33,73k | - |
| 2026-03-18 | PNG Enterprise FoundationSociété | 33,73k | 73,89k | Derivative Exercise and Retained Stock | 2,19 | 33,73k | - |
| 2026-03-16 | Mr. Paul L. GeyerIndependent Director | -48,73k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-08 | Dr. Richard M. GlickmanIndependent Director | -3,13k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-09 | Mr. Paul L. GeyerIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-09 | Mr. John Salvatore MontalbanoIndependent Director | -21,88k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-09 | Dr. Michael WilminkIndependent Director | -1,53k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-02 | Mr. Joseph S. FreedmanIndependent Director | 170,00k | 371,93k | Derivative Exercise and Retained Stock | 2,19 | 2,52M | 7,22% |
| 2026-02-20 | Mr. Joseph S. FreedmanIndependent Director | 280,00k | 1,96M | Achat | 7,00 | 2,35M | 13,50% |
| 2026-02-02 | Mr. John Salvatore MontalbanoIndependent Director | 243,90k | 534,87k | Derivative Exercise and Retained Stock | 2,19 | 1,54M | 18,87% |
| 2026-01-23 | Mr. Alexander John RothwellCFO | 104,00k | 227,19k | Derivative Exercise and Retained Stock | 2,18 | 1,10M | 10,40% |
| 2026-01-23 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 5,00k | 40,78k | Derivative Exercise and Retained Stock | 8,16 | 48,50k | 11,49% |
| 2025-12-15 | Dr. Richard M. GlickmanIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,27 | 260,00k | 8,33% |
| 2025-12-15 | Mr. Alexander John RothwellCFO | 231,25k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 446,25k | 107,56% |
| 2025-12-15 | Dr. Amanda MaloneChief Scientific Officer & COO | 285,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 861,00k | 49,61% |
| 2025-12-15 | Dr. Simon N. PimstoneIndependent Chairman | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 302,50k | 7,08% |
| 2025-12-15 | Mr. Paul L. GeyerIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 238,75k | 9,14% |
| 2025-12-15 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 80,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 340,00k | 30,77% |
| 2025-12-15 | Mr. John Salvatore MontalbanoIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 246,25k | 8,84% |
| 2025-12-15 | Dr. Mark M. KowalskiInitié | 85,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 395,00k | 27,42% |
| 2025-12-15 | Dr. Michael WilminkIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 222,50k | 9,88% |
| 2025-11-24 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 16,30k | 101,92k | Achat | 6,23 - 6,30 | 43,50k | 59,93% |
| 2025-11-15 | Dr. Simon N. PimstoneIndependent Chairman | 25,00k | 142,65k | Derivative Exercise and Retained Stock | 5,71 | 36,68k | 214,08% |
| 2025-11-14 | Mr. John Salvatore MontalbanoIndependent Director | 12,50k | 71,32k | Derivative Exercise and Retained Stock | 5,71 | 1,29M | 0,98% |
| 2025-11-02 | Dr. Simon N. PimstoneIndependent Chairman | -25,00k | 0,00 | Other Derivative Disposition | - | 282,50k | -8,13% |
| 2025-11-02 | Mr. Paul L. GeyerIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 218,75k | -5,41% |
| 2025-11-06 | Dr. James A. HelliwellCEO & Director | 100,50k | 53,32k | Derivative Exercise and Retained Stock | 0,53 | 875,01k | 12,98% |
| 2025-11-02 | Mr. John Salvatore MontalbanoIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 226,25k | -5,24% |
| 2025-11-02 | Dr. Amanda MaloneChief Scientific Officer & COO | -3,75k | 0,00 | Other Derivative Disposition | - | 575,50k | -0,65% |
| 2025-11-06 | Dr. James A. HelliwellCEO & Director | 100,50k | 35,43k | Derivative Exercise and Retained Stock | 0,35 | 875,01k | 12,98% |
| 2025-11-02 | Dr. James A. HelliwellCEO & Director | -18,75k | 0,00 | Other Derivative Disposition | - | 1,28M | -1,45% |
| 2025-11-02 | Dr. Michael WilminkIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 202,50k | -5,81% |
| 2025-09-23 | Dr. Richard M. GlickmanIndependent Director | 4,93k | 27,12k | Achat | 5,50 | 18,86k | 35,39% |
| 2025-09-26 | Mr. Joseph S. FreedmanIndependent Director | -1,50k | 0,00 | Other Disposition | - | 2,07M | -0,07% |
| 2025-09-26 | Mr. Joseph S. FreedmanIndependent Director | -3,50k | 0,00 | Other Disposition | - | 2,07M | -0,17% |
| 2025-09-24 | Dr. Simon N. PimstoneIndependent Chairman | 3,05k | 16,79k | Achat | 5,50 | 11,68k | 35,38% |
| 2025-09-24 | Mr. Joseph S. FreedmanIndependent Director | 240,79k | 1,32M | Achat | 5,50 | 2,08M | 13,11% |
| 2025-09-24 | Mr. John Salvatore MontalbanoIndependent Director | 67,27k | 370,00k | Achat | 5,50 | 1,28M | 5,55% |
| 2025-09-24 | Dr. Michael WilminkIndependent Director | 3,36k | 18,50k | Achat | 5,50 | 228,23k | 1,50% |
| 2025-05-13 | Dr. Simon N. PimstoneIndependent Chairman | 43,75k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 307,50k | 16,59% |
| 2025-05-13 | Mr. Paul L. GeyerIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 231,25k | 12,12% |
| 2025-05-13 | Mr. John Salvatore MontalbanoIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 238,75k | 11,70% |
| 2025-05-13 | Dr. Amanda MaloneChief Scientific Officer & COO | 12,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 579,25k | 2,21% |
| 2025-05-13 | Dr. James A. HelliwellCEO & Director | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,29M | 4,02% |
| 2025-05-13 | Dr. Michael WilminkIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 215,00k | 13,16% |
| 2025-06-16 | Mr. Joseph S. FreedmanIndependent Director | 33,40k | 134,95k | Achat | 3,89 - 4,34 | 1,53M | 2,22% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
